SoluPet Supplement’s Latest Research Reveals a Canine Cognition Crisis Is Coming
May 15 2024 - 6:08PM
Business Wire
Nearly One-Third of US Dogs Afflicted, Yet
Effective Solutions Elusive
As dogs age, they face a growing risk of cognitive decline akin
to humans. Recent research reveals that a staggering thirty (30)
million dogs in the US have visited their vets for cognition
concerns, yet viable treatments remain scarce. Among two of the top
interventions, fish oil and milk thistle, lack scientific backing,
leaving many dogs without adequate support. With the surge in dog
ownership during the Covid pandemic, the prevalence of Canine
Cognitive Dysfunction (CCD) is poised to escalate, demanding urgent
attention.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20240515440353/en/
(Photo: Business Wire)
The findings stem from a comprehensive research study conducted
by Dig Insights, a global tech-enabled market research company, who
surveyed US dog owners in April 2024. Alarmingly, only 5% of dogs
aged 11 and above have been formally diagnosed with CCD, suggesting
widespread underdiagnosis. Despite this, owners of senior dogs are
increasingly noticing behavioral changes indicative of cognitive
decline, such as altered sleep patterns and disorientation.
However, these symptoms often go unrecognized or unaddressed.
SoluPet Inc., a pioneering pet supplement company driven by
science and data, is leading the charge in combating CCD. Backed by
a team of experts in neuroscience, nanotechnology, and the pet
industry, SoluPet is ramping up to offer a revolutionary supplement
proven to halt dementia in animals. According to SoluPet's Chief
Veterinary Science Advisor, Dr. Paul Dick, “CCD poses a significant
threat to older pets, necessitating innovative solutions like
SoluPet's transformative supplement.”
Bill Mohri, Founder and CEO of SoluPet, says “I started the
company after seeing signs of dementia with our family dog, Lily,
and realizing there were so few efficacious products to treat her.
I decided I had to do something myself and sourced a novel product
and a stellar advisory team of neuroscientists, nanotechnologists,
and business leaders from the pet sector”.
Despite the prevalence of CCD, awareness among dog owners
remains relatively low, with only 31% having heard of the
condition. This underscores the need for increased education and
outreach efforts, particularly among older demographics.
Veterinarians emerge as pivotal players in this endeavor, not only
in diagnosing and treating CCD but also in fostering trust in
effective solutions like SoluPet.
Furthermore, the research underscores that 77% of dog owners are
interested in supplement products that are shown to be effective.
This presents a substantial opportunity for SoluPet to meet the
growing demand for cognition dog solutions.
As the canine cognitive crisis looms large, SoluPet's innovative
supplement stands as a beacon of hope for millions of aging dogs
and their owners. With the right awareness, education, and support
from veterinary professionals, the tide against CCD can be turned,
ensuring a brighter future for our lovable canine companions.
Investors and consumers interested in learning more about the
research findings or SoluPet should contact Bill Mohri at
bmohri@solupetsupplements.com or visit our website at
www.solupetsupplements.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240515440353/en/
SoluPet Inc Bill Mohri 416-428-1512
bmohri@solupetsupplements.com